PPT-Asthma/COPD in 30 minutes

Eric L Olson MD MSc FCCP Definition of Asthma A disease characterized by the following Airway obstruction that is reversible Airway Inflammation Increased airway responsiveness to a variety of stimuli. ALLERGIES. ASTHMA. COPD. Breathing is something we all need to do in order to . survive - and thrive. . ALLERGIES. ASTHMA. COPD -. C. hronic Obstructive Pulmonary Disease. …can make something as basic as breathing,. and BREATHING . Dr Christopher . Worsnop. Department of Respiratory and Sleep . Medicine. Austin Hospital, Melbourne, Australia. After a short visit to America, . David returns to Italy..  .   . OVERVIEW. . Mithra. , fy1. ASTHMA AND COPD. Objectives. Differentiate severity of acute asthma exacerbations. Pathophysiology. of Asthma and COPD. Discuss CXR and ABG. Type 1 . vs. Type 2 respiratory failure. D. aryl Freeman. on behalf of the Study Collaborators . Collaborators. Research in Real Life, Cambridge . David Price. Julie von . Ziegenweidt. Laurence . Mascarenhas. Annie Burden. Alison Chisholm. An Open Discussion. C. Michael Bowman, PhD, MD. Moderator. Today’s Speakers and You, the Audience. Active Contributors. Objectives for Discussion. Members of the audience will: . Reflect on the various discussion points from today’s talks;. Outline . Introduction. Definition. Epidemiology. Etiology. Cost & Burden. Intervention. Research. Introduction. Chronic Lower Respiratory Diseases. Chronic lower respiratory diseases. : . Asthma, bronchitis, COPD, emphysema, cystic fibrosis, bronchiectasis, pneumoconiosis, sleep apnea. Patient may or may not notice symptoms .. Life expectancy for stage 1 people is only slightly less than the normal people. . It is around 17.4 years for a male who is 65 year old. . Patients who continue smoking will have shorter life than who does not smoke or who stop smoking. . Finlay . Royle. Senior Clinical Commissioning Pharmacist. Lambeth CCG. 1. Medicines Optimisation . Key theme: . Quality. , . Safety . and . Medicines . W. aste. 2. Medicines are the most common therapeutic intervention in healthcare, but their use is often . in the Treatment of . Asthma and COPD. Margaret Miklich, . PharmD. , BCACP. Clinical Assistant Professor. 1. m. argaret.miklich@temple.edu. I have no conflicts of interest to disclose.. 2. Pharmacist Objectives. Updates inLaura Vaughan MDClinical Assistant Professor of MedicineStanford UniversityGINA slides used in this presentation are reproduced with permissionNo financial disclosuresSerious Consequences98 80 predicted and sometimes but not always Stage II Moderate COPD Worsening airflow limitation FEVbreath typically developing during exertion This is the stage at which patients typically seek medical The airway (bronchial tubes) can become swollen and the muscle around the airway tightens. . The result is a narrowed airway. Symptoms. Wheezing. Coughing. Shortness of breath. Chest tightness. Increased rate of breathing. Goals. Recognize common and uncommon presentations of COPD and asthma.. Make an appropriate assessment of the severity of illness.. Prescribe appropriate therapy. . Disposition the patient appropriately.. (leaning forward, hands on knees) when breathing difficulties occur. This provides a position that . optimizes respiratory mechanics.. 1-Introduce yourself. 2-Identity of patient – confirm.. 3-Permission (consent and explain examination).